Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF in chronic hepatitis B after multiple nucleos(t)ide treatment failures
ChiCTR-OCH-14004224Phase 3Completed
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB) (2 arms), sponsored by Shenzhen Third People's Hospital. Primary endpoints: HBV-DNA normalization rate, ALT and 3 more. Started Mar 2012; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OCH-14004224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14004224.